Protagonist Therapeutics, Inc. earnings per share and revenue

PTGX earnings per share for the last quarter are -0.50 USD whereas the estimation was -0.60 USD which accounts for 16.02% surprise. Company revenue for the same period amounts to 4.17 M USD despite the estimated figure of 3.14 M USD. Estimated earnings per share for the next quarter are -0.58 USD, and revenue is expected to reach 2.21 M USD. Also watch annual changes over time to get a bigger picture of PTGX earnings per share and revenue dynamics.